(BOSTON, MA) December 3, 2019 — Today, Invicro LLC, a Konica Minolta Company, has joined Accenture’s open partner ecosystem—the INTIENT™ Network—which is designed to help solution providers, software vendors and life sciences companies’ team more effectively to accelerate drug discovery and improve patient outcomes. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development.
(BOSTON, MA) November 20, 2019 – Invicro LLC, a Konica Minolta Company, today announced the expansion of their Software leadership team with the hiring of Mr. Chris Fuller, Vice President of Software and Mr. Timothy Moran as Senior Director of Product Management. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development.
NEW PROVIDENCE, N.J. and BOSTON, MA, November 18, 2019 — Today, Evolution Research Group (ERG) and Invicro LLC, a Konica Minolta Company announced a strategic partnership to offer biotech and pharma sponsors early to late phase clinical research trials, advanced data analysis and project management services.
(Boston, MA) September 16, 2019 – Invicro, a Konica Minolta company and a leading provider of imaging biomarkers, core lab services and software for research and drug development appoints Evan Morris, Ph.D. as VP of Scientific Imaging Research, New Haven.
(BOSTON, MA) August 29, 2019 – Invicro LLC, a Konica Minolta company and a leading provider of imaging biomarkers, core lab services and software for research and drug development, today announced the appointment of Mr. Hidenori Seshimo, M. Eng. as Vice President of Biomarker Services, Japan.
(Boston, MA and Munich, Germany) April 30, 2019 – Invicro LLC, a Konica Minolta company and iTheraMedical GmbH announced a unique partnership with the placement of the MSOT inVision platform in Invicro’s in vivo laboratory out of its Boston headquarters. Both companies will come together to uniquely offer Pharmaceutical, Biotech and Academia sponsors services from the optoacoustic platform that will identify and quantify disease-related biomarkers at both a molecular and anatomical level through pre-clinical full body tomographic scans.
(Boston, MA and Leuven, Belgium) February 25, 2019 – Invicro LLC, a Konica Minolta company and icometrix jointly announced a partnership that will seamlessly offer the world’s most comprehensive breadth of imaging core lab services combined with the most robust FDA-cleared MRI informatics capabilities through automated workflows. Pharmaceutical sponsors will experience one point of contact for study site set-up and training which will harmonize with a single platform for data management, sharing and analytics.
BOSTON, MA, February 14, 2019 – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the hiring of Dr. Joseph Krueger as Vice President, Research and Applications for Advanced Pathology Services.
Tokyo, Japan (September 26, 2018 – article source from Business Wire): Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902) (ISIN: JP3300600008) today announced the launch of Konica Minolta Precision Medicine Japan, Inc. (“KMPMJ”) which will start operations on October 1, 2018. KMPMJ is a 100%-owned subsidiary of Konica Minolta with responsibility for marketing high-end precision medicine tools and diagnostic services in Japan. Precision medicine is medical care that uses genetic and molecular profiling to optimize treatment for specific groups of patients.
Toronto, Canada (August 20, 2018): Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to work together on multiple projects, initially focusing on the enhancement of Invicro’s AmyloidIQ and TauIQ platforms. EBG will be responsible for providing data from their affiliate companies; Cerveau Technologies, Inc. and Meilleur Technologies, Inc.; novel Tau tracer (MK-6240) and Amyloid tracer (NAV-4694); respectively.